Wczytywanie kursów wyceny...
Prognoza
Nie mamy danych analityków dla tej spółki.
Wiadomości Przejdź do aktualności
Springer Nature appoints Patric Somlo as chief financial officer
Springer Nature appoints Patric Somlo as chief financial officer effective 1 November. Somlo most recently served as Senior Vice President Corporate Finance at Lonza and brings experience from private equity, management consulting and investment banking. He succeeds Alexandra Dambeck, who is moving to Dürr in mid-November. » Więcej na finanzen.net
Springer Nature raises 2026 revenue forecast after strong half-year growth
Springer Nature reported currency-adjusted revenue growth of 6% to €940m for H1 2026 and an adjusted operating profit increase of 8% to €246m; the adjusted operating margin improved by 38 basis points. Free cash flow rose to €268m and net leverage fell to 1.6x. The research segment remains the growth driver with around 80% of revenue; Open Access and higher article publications drove the growth. Management raised the full-year outlook for currency-adjusted revenue growth to about 6% and cites AI initiatives as a strategic focus; the shares rose about 2.9%. » Więcej na de.investing.com
Springer Nature raises full-year outlook after strong first half
Springer Nature has raised its forecast: organic revenue growth is now expected to be around 6% (previously 5–6%), and the operating margin is forecast to improve by at least 0.3 percentage points. In the first half, group revenue rose 1.5% to €939.8m (organic 6.2%) and adjusted operating income increased to €246.2m. Analysts highlighted the stronger numbers, the share price rose sharply, while net profit fell to €101.3m, in part due to higher taxes and currency effects. » Więcej na finanzen.net
Historyczne dywidendy Dywidendy
Wszystkie wskaźniki dywidendowe Wszystkie wskaźnikiDane finansowe spółki
| (EUR) | czerwiec 2026 | YoY |
|---|---|---|
| Przychody | 939,8 mln | 1,50% |
| Zysk brutto | 375,2 mln | 0,95% |
| Zysk netto | 101,3 mln | 21,72% |
| EBITDA | 340,2 mln | 30,16% |
Dane fundamentalne
| Wskaźnik | Wartość |
|---|---|
Kapitalizacja rynkowa | 4,07 mld € |
Liczba akcji | 198,89 mln |
Maksimum/minimum z 52 tygodni | 23,50 € - 14,76 € |
Stopa dywidendy | 3,99% |
Dywidendy TTM | 0,83 € |
Beta | -0,09 |
C/Z (PE Ratio) | 8,25 |
PEG (PEG Ratio) | 0,08 |
C/WK (PB Ratio) | 2,03 |
C/S (PS Ratio) | 1,39 |
Profil spółki
| Nazwa | Springer Nature |
| CEO | Franciscus Vrancken Peeters |
| Debiut giełdowy | 02.10.2024 |
| Pracownicy | 9400 |
Symbole giełdowe
| Giełda | Symbol |
|---|---|
XETRA | SPG.DE |
Frankfurt | SPG.F |
Düsseldorf | SPG.DU |
Hamburg | SPG.HM |
München | SPG.MU |